Big 5 Sporting Goods Corp. (Nasdaq:BGFV) CEO Steven Miller rebuffs assertions by board member DeMarco; Norfolk Southern Corporation (NYSE:NSC), Harvard Apparatus Regenerative Technology, Inc. (Nasdaq:HART)

Big 5 Sporting Goods Corp. (Nasdaq:BGFV) CEO Steven Miller rebuffs assertions by board member DeMarco. Big 5 Sporting CEO Steven Miller sent a letter to board member Dominic DeMarco addressing a number of concerns brought by DeMarco. Miller wrote, in part, "Suffice it to say that we strongly disagree with many of the assertions in your letter... We are surprised by your reaction to the formation of a special committee of the board to consider the shareholder proposal and other corporate governance proposals made by your employer, Stadium Capital Management...”. BGFV closed for the day at $11.91 with a change of $0.60. Trailing 12 month’s profit margin for BGFV is 1.77% and for the same period, its operating margin is 3.10%.

 

Norfolk Southern Corporation (NYSE:NSC), BLET reach five-year collective bargaining agreement. Norfolk Southern and the Brotherhood of Locomotive Engineers and Trainmen reached a new collective bargaining agreement that continues to link engineer compensation to corporate performance through 2019. The agreement, which covers approximately 4,600 locomotive engineers, provides engineers with an annual bonus opportunity based on corporate performance and for the first time includes individual incentive opportunities based on personal performance. The closing for NSC was $101.97 at the day’s end. It was a change of $1.82. NSC saw a market cap of $31.43B and its Trailing P/E was 15.96.

 

Harvard Apparatus Regenerative Technology, Inc. (Nasdaq:HART) says will need more testing, development of HART-Trachea. Harvard Apparatus Regenerative Technology recently determined that it will need additional development and testing within its ongoing preclinical large-animal model testing of the HART-Trachea. The company believes that the additional testing needed is readily achievable, however, it estimates that this testing will require an additional 2 to 6 months beyond the company’s previous estimates. In Nasdaq, HART traded with a change of $0.06 and closed for the day at $3.25 with a volume of 5,400 shares. HART‘s revenue in last one year has been $70.00K, return on assets -137.09 % and return on equities -246.70% .